CIK 0001425205 · Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753254381
- Phone
- 6502607120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- CORRESP Other Correspondence Between Filers and SEC Staff
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Executive or director change
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- POS AM Other Post-effective Amendment for Registration Statement
- DEFA14A Proxy Proxy Materials
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Insider Changes in Ownership
Page 35 of 53 · 1,049 filings